Evotec SE ADR (EVO) Stock Analysis

Evotec SE ADR (EVO) is a publicly traded company in the HEALTHCARE sector. It trades at $2.95, carries a market capitalization of $1.09B. This page summarizes the public market data, fundamentals, and frequently asked questions for EVO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $2.95
• Market Cap: $1.09B
• EPS: $-0.63
• 52-Week High: $4.44
• 52-Week Low: $2.31

Market Sentiment

Evotec SE ADR currently has a Bullish sentiment score of 0.19.

About Evotec SE ADR

None

GNG Research Analysis

GNG Research scores Evotec SE ADR (EVO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for EVO.

Frequently Asked Questions

Does EVO pay dividends?

Evotec SE ADR (EVO) does not currently pay a regular dividend.

What is EVO's market cap?

Evotec SE ADR (EVO) has a market capitalization of $1.09B with a current stock price of $2.95.